Drug Channels Institute (DCI) is a leading source of industry research about pharmaceutical economics and the drug distribution system. >

Industry Reports

The 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

The ultimate guide to the complex web of interactions within the U.S. prescription distribution and reimbursement system more >

The 2026-27 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors

The most comprehensive tool for analyzing the economic and business realities of the U.S. pharmaceutical distribution industry. more >

From The Drug Channels Blog

Drug Channels News Roundup, November 2026: MedImpact’s VytlOne Deal, Medicare Drug Negotiation Final Rule, Part D Premium Surprises, 340B Hospital Spending, and a Part D Glossary

By Bryce Platt, PharmD What do you talk about around the Thanksgiving table or while watching the 100th Macy's Thanksgiving Day Parade? more >

The Direct-to-Patient Opportunity: Evolving Pharma’s DTP Strategy for Lasting Patient Engagement

Today's guest post comes from Sahil Naik, Chief Growth Officer at PHIL Inc. Sahil examines how direct-to-patient programs may be able to support affordability and patient engagement throughout the more >